Movano, Inc. (MOVE)
| Market Cap | 152.18M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -21.95M |
| Shares Out | 29.55M |
| EPS (ttm) | -0.74 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 14 |
| Last Price | $5.15 |
| Previous Close | $5.00 |
| Change ($) | 0.15 |
| Change (%) | 3.00% |
| Day's Open | 5.00 |
| Day's Range | 5.00 - 5.15 |
| Day's Volume | 31,542 |
| 52-Week Range | 5.00 - 7.45 |
TORONTO--(BUSINESS WIRE)---- $MOVE #NEOExchange--Clean Power Capital Corp. (NEO:MOVE), previously listed on the Canadian Securities Exchange, has graduated to the NEO Exchange.
As the pioneer of the first FDA-approved continuous glucose monitor, Dr. Mastrototaro will be integral in advancing the development and regulatory process of the Company's glucose and blood pressure mon...
PLEASANTON, CA / ACCESSWIRE / March 25, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to prevent and better ...
Movano, which is developing a wearable device for measuring glucose, blood pressure, and heart rate, filed on Tuesday with the SEC to raise up to $41 million in an initial public offering.
Movano, Inc. has filed to go public with an IPO on the NASDAQ.
About MOVE
Movano is a health-focused technology company developing a proprietary platform that uses Radio Frequency (“RF”) technology, which we believe will enable the creation of low-cost and scalable sensors that are small enough to fit into a wearable, and other small form factors. We expect that our platform will provide users with the ability to measure and continuously monitor vital health data and provide actionable feedback to jumpstart changes in behaviors. Our platform is the foundation for our first product in development, which is a non-i... [Read more...]
| Industry Scientific & Technical Instruments | IPO Date Mar 23, 2021 |
| CEO Michael Leabman | Employees 15 |
| Stock Exchange NASDAQ | Ticker Symbol MOVE |